http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TR-199902537-T2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f00b503b4045fc858275a7c77e27c087
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4747
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06Q10-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-547
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-537
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 1998-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_314f2bdcb67a7de4bf8157cf86d8d8d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e437aa3d64c0042007aa13759d38fa6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a11bece7929dd45b4d937d515918d004
publicationDate 2000-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TR-199902537-T2
titleOfInvention compositions
abstract New compounds of Formula (I) are presented such that A is a benzo ring, which is a six-membered heterocyclic aromatic ring containing 1-3 nitrogen atoms, or selected from O, N and S, which may be the same or different. represents a five-membered heterocyclic aromatic ring containing heteroatoms; R1, R2, R3, and X as well as their pharmaceutically acceptable salts, enantiomers and tautomers have been identified. their preparation, their combination and their use in therapy. These combinations are inhibitors of nitric oxide synthase and are therefore particularly useful in the treatment of inflammatory disease and pain, or prevention from these diseases and pain.
priorityDate 1997-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27571
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO61608
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID34495
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4328006
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO61309
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9I9M2
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8T8C0
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID692510

Total number of triples: 40.